Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 5 completed trials

    Completion Rate
    100%(5/5)
    Active Trials
    0(0%)
    Results Posted
    40%(2 trials)

    Phase Distribution

    Phase 2
    1
    20%
    Phase 1
    3
    60%
    Phase 1/2
    1
    20%

    Phase Distribution

    3

    Early Stage

    2

    Mid Stage

    0

    Late Stage

    Phase Distribution5 total trials
    Phase 1Safety & dosage
    3(60.0%)
    Phase 1/2Combined phases
    1(20.0%)
    Phase 2Efficacy & side effects
    1(20.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    5 of 5 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    5

    all time

    Status Distribution
    Completed(5)

    Detailed Status

    Completed5

    Development Timeline

    Analytics

    Development Status

    Total Trials
    5
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 1/2

    Trials by Phase

    Phase 13 (60.0%)
    Phase 1/21 (20.0%)
    Phase 21 (20.0%)

    Trials by Status

    completed5100%

    Recent Activity

    0 active trials
    Showing 5 of 5
    completedphase_1

    Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin

    NCT06551623
    completedphase_2

    Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants

    NCT06076694
    completedphase_1_2

    A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules

    NCT06076681
    completedphase_1

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants

    NCT06081699
    completedphase_1

    A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

    NCT06081712

    Clinical Trials (5)

    Showing 5 of 5 trials
    NCT06551623Phase 1

    Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin

    Completed
    NCT06076694Phase 2

    Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants

    Completed
    NCT06076681Phase 1/2

    A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules

    Completed
    NCT06081699Phase 1

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants

    Completed
    NCT06081712Phase 1

    A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

    Completed

    All 5 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    5